HRO

Harrow

HROW • NASDAQ • Stock Fundamentals

Harrow is a medical - pharmaceuticals company in the healthcare sector trading on NASDAQ, led by CEO Mark L. Baum, with a market cap of $1.3B.

Market Cap$1.3B

Employees382.0

CEOMark L. Baum

CountryUnited States of America

Healthcare

Medical - Pharmaceuticals

Most Recent EarningsMay 11, 2026 · 1 month 1 day agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

HRO

Common questions about Harrow

Harrow (HROW) has a market capitalization of $1.3B and trades on NASDAQ.

Harrow has approximately 382 employees.